Maxima Reverse Transcriptase (200 U/uL), 4 x 10,000 Units
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446608
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $2,100
About this award
Life Technologies Corporation was awarded contract A207_PO-0446608 by the University of Virginia on June 9, 2026, with a cumulative contract value of $2,099.52. The contract is classified under Virginia state procurement and involves the delivery of specialized laboratory reagents to the University of Virginia's Matthew S Loftus.
The primary deliverable under this contract is Maxima Reverse Transcriptase at a concentration of 200 units per microliter, supplied in quantities of 4 x 10,000 units. The University of Virginia has ordered three units of this product at a unit price of $699.84 each. Reverse transcriptase is an enzyme commonly utilized in molecular biology research and diagnostics for synthesizing complementary deoxyribonucleic acid from ribonucleic acid templates, and the procurement reflects the University's research or laboratory operations requirements.
Line items
| Item | Total |
|---|---|
| Maxima Reverse Transcriptase (200 U/uL), 4 x 10,000 Units | $2,099.52 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446608?
Contract A207_PO-0446608 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 9, 2026.
How much is contract A207_PO-0446608 worth?
Its cumulative value is $2,100.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award